ABSTRACT
SAŽETAK

Protein 53 je značajan za regulaciju ćelijskog ciklusa i njegova pojačana ekspresija se viđa kod malignih tumora. Naš cilj je ispitivanje povezanosti ekspresije p53 sa proliferacijom ćelija i ispitivanje njegove uloge u patogenezi keratinocitnih tumora kože. Korišćen je biopsijski operativni materijal skvamocelularnog karcinoma (SCC), aktiničničnih keratoza (AK) i keratoakantoma. Na presecima debljine 4µm , su primenjene rutinska HE i imunohistohemijska ABC metoda sa anti-cytokeratin, anti-p53 i anti-
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INTRODUCTION
Keratinocyte skin cancers are clinically and histopathologically heterogeneous group of lesions, caused by the proliferation of epidermal and adnexal keratinocyte. On the one side of the keratinocyte spectrum are a number of benign proliferation, whilst at the other end are malignant tumors which, not infrequently, have aggressive course with metastatic potential, such as squamous cell carcinoma (1, 2) . Actinic keratosis also belongs to this keratinocyte spectrum (1) . At the same time, keratinocyte tumors are the largest group of tumors of the skin, which is associated with these extreme fluctuations of climatic and meteorological factors, depletion of the ozone layer, ultraviolet and ionizing radiation (3, 4, 5) . In addition to ultraviolet radiation, ionizing radiation and thermal damage to the chronic, frequent exogenous carcinogens are cigarette smoking, human papilloma virus, arsenic, vinyl chloride, polycyclic aromatic hydrocarbons, insecticides, herbicides, cadmium, etc. (6) .
About 20% of keratinocyte skin cancers represents squamous cell carcinoma, which is the second most frequent of all cancers in the white population (1) . In more than 90% of cases tumor is localized on the face, lower lip, neck, ear lobes and dorsal hand side, but can also have specific localisation on tongue, penis or vulva. Surrounding skin usually shows features of acantholytic damage (7 ) . Clinically, it is most commonly presented as shallow ulcers often with ceratotonic crust and elevation of indure environment. Tumor sometimes begins as hyperkeratotic or verrucous focal point. Progression is followed by tumor enlargement, and when it reaches a few centimeters ulcers or necrosis might occurre. During enlargement tumor is spreading in softt tissue, cartilage, and bone. It can metastasize to lymph nodes and distant tissues and organs (7, 8) .
Squamous cell carcinoma can arise de novo or from precursors such as actinic keratosis. A deregulation of the cell cycle is one of the most common changes during carcinogenesis (9) . Cell unwinding cycle is highly organized and highly regulated process that involves a number of checkpoints, and ensures complete and accurate replication of DNA and cell components before the division. Carcinogenesis is the consequence of accumulation of disorders in the structure and function of genes regulating mechanisms of cell proliferation, DNA repair and apoptosis in the molecule. These are the oncogenes, tumor suppressor genes and genes controlling programmed cell death (10, 11, 12) .
The most frequently mutated gene is TP53, located in humans on the short arm of chromosome 17 (17q13).
Its importance is reflected in itsrole in suppressing cell transformation and tumorigenesis, Therefore it belongs to the class of typical suppressor gene. TP53 is organized in 11 egzogenic sequences encoding the synthesis of the p53 protein which plays an important role in cell cycle regulation and preserving stability of the genome (13, 14) . Considering scarce and controversial results about the expression of p53 in the skin tumors of the keratinocyte histogenesis, in this study we investigated the association of p53 expression with proliferative index and clinicopathological characteristics of keratinocyte skin cancers.
MATERIALS AND METHODS
Patients and tissue samples
The study included 78 patients who underwent excision me-melanoma skin cancer in the period from January 1 st to December 1 st , 2008 in The centre for Plastic surgery in Clinical Center Kragujevac. Tissue samples were fixed in 10% buffered formalin solution, and after routine processing in autotehnicon, tumor tissues were embedded in paraffin and archived in The center of pathology in Kragujevac. Tissue sections (3-4μm) were stained with hematoxylin-eosin for histomorphological analysis of the tumor differentiation. For immunohistochemical staining we used paraffin embedded sections (3-4μm) and ABC method with anti-cytokeratin, anti Ki67-and anti p53-antibodies.
The study included 33 squamous cell carcinoma, 30 actinic keratosis and 15 keratoacanthoma. Patient clinicopathologic parameters are shown in Table 1 . The study protocol was approved by the local Ethics Committee.
Immunohistochemistry
Paraffin sections were heated at 55 o C to melt the paraffin, deparaffinized in xylene for 5 min three times and them rehydrated in a series of 100%, 96%, 70% and 50% alcohol. Antigen retrieval was performed by microwave heating for 20 minutes in 10 mM sodium citrate buffer (pH 6. 0). Endogenous peroxidase activity was blocked by 3% H 2 O 2 in methanol for 20 min. Rabbit monoclonal Ki67 antibody (Abcam, Cambridge, UK; 1:100 dilution) and monoclonal mouse anti-human p53 (DAKO Denmark; 1:100 dilution) and monoclonal mouse anti-cytokeratin antibody (clone AE1/AE3; DAKO Glostrum, Denmark;1:200 dilution) were incubated at +4 0 C overnight. Immunostaining was performed by the ABBREVIATIONS SCC -squamous cell carcinoma, AK -actinic keratosis KA -keratoacanthoma avidin-biotin peroxidase complex (ABC) method (Vectastain ABC-Elite kit, Vector Laboratories, Burlingame, CA). Staining was visualized with 3, 3 diaminobenzidine tetrachloride (DAB). The slides were counterstained with Mayer hematoxylin and mounted in Canada balsam. Negative controls were done by replacing the primary antibody with phosphate buffered solution (PBS). The slides were examined by conventional light microscopy.
Quantification of immunohistochemical staining
In evaluating the expression of Ki67 and p53, only stained nuclei were taken into account, while for the evaluation of Ki67-positive cells per mm 2 by area the multipurpose test system M42 by Weibel was used. The objective micrometer (Reichert Wien 2mm/200) was used to determine the measuring area of 0. 016 mm 2 For testing Ki67 and p53, positive cells/mm 2 were counted successively by 10 "hot spots". The absolute value of the density of positive cells in the "hot spot" was determined stereometrically (15) . The arithmetic mean of the obtained values of the "hot spots" represented the final number of Ki67 and p53 positive cells per mm 2 per case. The median was subsequently determined and the absolute values of the density of positive cells were divided into two groups: those with low expression level (value ≤ the median value) and those with high level of expression (values > the median value). These values represented the proliferative activity (proIDX). (1 + 2 + low or high index). It is also referred to an absolute value of a p53 in relation to deviation from the median obtained index of p53 expression (1 + 2 + or low: high). Cytokertine expression was not evaluated since cytokeratine antibody was used as a differencial marker for keratinocyte tumors. 
Statistical analysis
RESULTS
Total number of patients with keratinocyte skin tumors was 78, and the average age of subjects was 69, 58 (range 32-88). Squamous cell carcinoma (SCC) was found in 33 patients and the average age was 73. 39 years. In the group with actinic keratoses (AK) 30 subjects were found, mean age 67, 37, while in the group with keratoacanthoma (KA) , 15 to 70 years of age , there were the following results: SCC=3, AK= 9, KA=4. In the group of the patients from 71 to 80 years of age , distribution is: SCC=20, AK=13, KA=5, while in the age group from 81 to 90 years of age , distribution was the following SCC=6, AK=1, KA=1. In the group of patients with SCC , 57. 58% of them were male and 42. 42% female, in patients with AK 50% were male and 50% female. In patients with KA 46. 67% of them were male and 53. 33% female. There were no significant correlations between the type of keratinocyte tumor and gender of patients, but we have noticed that in the SCC group, male subjects have been more affected (Table 1) .
A statistically significant relation is noticed among the patient age and the patient type tumor carcinoma. Average age of the patients with SCC is statistically significantly higher than average patient age with AK (Mann-Whitney U test; р=0, 002) and also from average patient age range with the KA (Mann-Whitney U test; р=0, 006). There was no difference in average age between the patients with AK and the patients with KA (Mann-Whitney U test, р=0. 718). (Table 2 ). There was a statistically significant difference in the prevalence of patients with different tumor localization. In SCC and AK groups, tumor localization was significantly more often on photoexposed region (Chi-sqare test p = 0. 000), but there were no significant difference in the occurence of KA at photoexposed region and photo-non exposed (Chi-sqare test r = 0. 549 ). There is a significant difference in tumor occurrence in the region between photo-exposed SCC and KA (Chi-sqare test r = 0. 001) and between the AK and KA (Chi-sqare test p = 0. 001). SCC is significantly more likely to occur in the photo exposed region (93. 9% of cases) compared to KA (53. 3% of the cases). AK was also significantly higher (93. 3% cases) on photo-exposed region compared to KA (Chi-sqare test r = 0. 001). Between AK and SCC no significant differences in the incidence of the photo -exposed region was found.
(Chi-sqare test r = 0. 942) (Fig. 1) .
High proliferative index was found in 75. 8% of cases in the SCC group, 6. 7% in AK and 73. 3% in the KA. Percentage of patients with high proliferative index was highest in SCC and KA groups, and also there were no difference between these two groups. High proliferative index was significantly less frequent in AK in relation to the SCC (Chi-sqare test p = 0. 000) and KA (Chi-sqare test p = 0. 000). Low proliferation index was found in 24. 2% of cases in SCC group, in 90. 0% ofpatients in AK group and 26. 7% of the patients in KA group. Low proliferative index prevalence was significantly higher in AKcompared to SCC (Chi-sqare test; p = 0. 000) and KA (Chi-sqare test p = 0. 000) ( Table 3) .
There is significant correlation between the proliferation index (Ki67 expression) and the tumor of localized photo exposed region. The biggest number of patients with SCC (70%) has a high index of proliferation of the photo-exposed region, while in the AK patients there was significant corelation between the photo exposure region and the moderate proliferative index, that is encountered in 83% of cases (Spearman's corelation p = 0. 025). (Fig.  2) . The connection between the high index of proliferation and tumor localization was not observed in the KA group.
A statistically significant number of men have a high proliferative index in comparison to women in SCC (Chisqare test, p = 0. 015) ( (Table 3) . There is a correlation between p53 expression and tumor localization. We demonstrated a positive correlation between p53 expression and photo exposure of tumor regionin SCC and AK. Significantly more patients with SCC 64% and AK47% has a high index of p53 expression on photo exposed tumor region(Spearman's correlation, p = 0. 000). (Figure 2) . Correlation between the expression of this marker and localization was not observed in the KA. Significantly more women have absence of p53 expression in KA compared to men (Chi-sqaretest, p = 0. 031), while a statistically significant number of men have low index of p53 expression compared to women in SCC (Chi-sqare test, p = 0. 014 ) ( Table 4) . In patients younger than 60 years of age, frequency of high index of p53 expression was significantly higher in the SCC compared to KA (Chi-sqare test , p = 0. 000). In this population there were no statistically significant difference in the prevalence of high index of p53 expression between the SCC and the AK, but the high index of p53 expression was significantly more frequent in the AK compared to KA (Chi-sqare test, p = 0. 000). The low index of p53 expression was significantly less frequent in SCC compared to AK, and also significantly more frequent in the AK compared to KA. In this group of patients the absence of p53 expression was significantly lower in the SCC and the AK compared to KA (Table 5 ).
In the group of respondents aged 61 to 70 years, a high index of p53expression was significantly more common in AK compared to SCC and KA, and statistical significance was not found between the SCC and KA. Low index of p53 expression were significantly more prevalent in the AK as compared to SCC and KA. Significantly more patients with SCC have a low index of p53 expression as compared Level of p53 expression 0 -p=0,000** p=0,000** -p=0,001** p=0,05* ----p=0,000** p=0,000** 1 p=0,042* -p=0,009** p=0,05* p=0,001** p=0,000** -p=0,000** p=0,014* p=0,000** p=0,000** -2 -p=0,000** p=0,000** p=0,000** -p=0,000** p=0,027* p=0,000** p=0,001** p=0,000** p=0,000** p=0,000** to KA. The absence of p53 expression was significantly lower in the SCC and the AK in relation to keratoacanthoma. (Table 5 ).
In subjects 71 to 80 years of high index of p53 expression were significantly more frequent in SCC compared to AK and KA, as well as AK in relation to KA. Low index of expression of this protein is significantly more common in SCC and the AK compared to KA. , Between AK and SCC there were no statistically significant differences in the low expression of p53. Also, in this population there was no significant difference in the absence of p53 expression between the different tumor types (Table 5 ).
In the group of subjects aged 81 to 90 years, high index of p53 expression was significantly more frequent in SCC compared to AK and KA, as well as in AK compared to KA. The low index of p53expression was significantly more frequentin SCC compared to AK and KA, while between the AK and KA there were no significant difference in the low p53 expression. The absence of p53 expression was significantly lower in patients with SCC and the AK compared to KA, while between the AK and the SCCno difference was found. (Table 5 ).
In patients younger than 60 years of age high index of expression of Ki67 was significantly more frequent in SCC and KA compared to AK, and statistically significant difference was not found between SCC and KA. The low index of expression of the p53 is significantly less frequent in SCCthan in AK, whereas statistical significance was not found between the SCC and KA. In this group of patients there is no statistical significance in the absence of the expression of Ki67 and tumor types.
In the group of respondents aged 61 to 70 years, a high index of expression of Ki67 was significantly more frequent in SCC and KA relative to AK, and statistical significance was not found between the SCC and KA. Low index of expression of Ki67 were significantly more frequent in AK in relation to the SCC and KA, while significantly more subjects with KA has a low index of expression of Ki67 in comparison to the SCC. The absence of expression of Ki67 was significantly less for SCC and KA in comparison to the AC, while between the SCC and KA there is no statistical significance.
In subjects aged from 71 to 80 years, high index of Ki67expression was significantly more frequent in SCC and KA in comparison to the AK, and between SCC and KA no difference was found. Low expressionindex of this protein is significantly more common in AK compared to SCC and KA, while between SCC and KA no difference was found. In this population subjects there was no significant difference in the absence of the Ki67expression between different tumor types.
In the group of subjects aged from 81 to 90 years, high index of expression of Ki67 was significantly more frequent in SCC compared to AK and KA, as well as the KA with respect to AK. The low index of expression of Ki67 is significantly more frequent in AK compared to SCC and KA, as in SCC compared to KA. In the study group, there were no significant difference in the absence of the Ki67expression in various tumor types. Correlation analyzes of Ki67 and p53 expression in a keratinocyte tumors demonstrated a significant positive correlation between these two markers in the SCC (p<0. 05 p=0. 028; Spearman's rho 0, 377). Correlation between the expression of Ki67 and p53 was not found in the AK and KA.
DISCUSSION
The development of squamous cell carcinoma is a multistage process in which a number of molecular disorders occurs that lead to neoplastic transformation of keratinocytes. The key events in keratinocyte carcinogenesis include activation of protooncogenes and inactivation of tumor suppressor genes. A classic example of a suppressor gene is a gene TP53 which encodes a multifunctional protein p53. Somatic mutations of this gene are the most frequent gene mutations in human cancers, and has been estimated to occur in 50-90% of malignant tumors, depending on the type and stage of the tumor (16, 17) . From 1989. till today, in over 2700 published papers numerous evidences for more than 35000 TP53 mutations were described (18, 19) . The mutated gene is changing the structure and function of the encoded protein, initiate the process of oncogenesis and lead to accumulation of p53 in tumor tissue (20, 21) .
As expected, reports on the expression of p53 in keratinocyte tumors are quite heterogeneous. In our study, the expression of p53 was present in 87. 8% of SCC, 83. 3% of AK and 13. 4% of KA patients, which is consistent with previous reports of Karagece et al and Park et al (22, 23) . However , Dornelas et al have recently demonstrated the expression of p53 in all cases (100%) tested in the SCC and the AK (24) , while in the study of Khodaeiani et al, p53 was detected in 50. 20% of SCC, and was absent in KA patients (25) . Almost more than two decades ago, Lee et al. demonstrated that p53 expression was present even at the 78. 8% of the tested KA and 75. 5% of the SCC (26) . In our study, we showed significantly higher frequency of high index of p53 expression in the SCC and the AK in relation to KA. These findings are in favor of concept that the common factor, such as actinic damage may be responsible for both lesions (SCC and the AK). In the other hand, majority of SCC is a p53 pozitive, regardless of whether they are localized on the photo exposed parts of the body or not, which indicates that, in addition to actinic damage, in the keratinocyte carcinogenesis other pathogenetic mechanisms can also be involved (26, 27, 28) A statistically significant majority of our patients with SCC and the AK has a high index of p53 expression in tumors that are localized to the photo exposed region. Numerous reports confirmed that keratinocyte tumors occurring as a result of exposure to ultraviolet radiation (3, 29, 30, 31) . About 90% of UV radiation consists of UVA rays (320-380 nm in the solar spectrum), while the UVB rays (290-320 nm in the solar spectrum), make up about 1-10% of the UV radiation. However, when absorbed by the keratinocyte DNA, UVB rays cause genotoxicity and mutations of the p53 gene (24 29, 32) . P53 induction is detected in the skin after 30 minutes after exposure to UVB radiation (33) . The presence of p53 expression in a high percentage (83. 3%) in the AK, in this study, confirms the observation that the mutation of the p53 gene is early event in keratinocyte carcinogenesis (32) . P53 belongs to transcriptional factors and when enabled, allows the expression of several genes, one of which is p21, which belongs to the group of inhibitors of cyclindependent kinases (CKIs), and arrest cells in the G1 phase of the cell cycle. Protein p53 can halt the progression of the cycle in the G2 phase and even during mitosis. In the case of irreversible damage to the DNA p53 induces the activation of apoptosis (31) . Mutational events form that inactivate p53 is specific for each individual tumor. It has been noted that the loss of p53 function, in patients with SCC, is most frequently associated with mutation of cytosine and thymidine dimer (so called "tandem mutation") (32, 34) .
The absence of p53 expression in tumor islands with pronounced keratinization, in well-differentiated SCC, and high index of p53 expression in poorly differentiated SCC, suggests that the presence of p53 is indicator of the immaturity of the tumor cells and the proliferative capacity of tumors. In accordance with this interpretation is the observation that high-grade tumors have a higher level of expression of p53 (35) .
In this study, there were no significant differences in the prevalence of high index of expression of p53 between the SCC and the AK, and at the same time, a positive correlation between the expression of p53 in these tumors and localization in photoexposed region was shown. It was also observed that between SCC and AK there is no significant difference in the incidence of the photoexposed region. These results were supported by the concept that the exposure to UV light is the main cause of p53 mutations. This is supported with the report of Batinac et al, in which the expression of the p53 was detected in 39. 0% of cases in the normal epidermis exposed to UV radiation (35) . There are suggestions in the literature that the expression of p53 is correlated with poor prognosis and / or a lack of response on therapy (25, 36) .
Most keratinocyte tumors with high proliferation index were in the group with SCC and KA, which is to be expected since these two histologically similar tumors have a pattern of growth, including cytologic atypia and infiltration (37). Despite the fact that between the two types of tumor there were no differences in the prevalence of high proliferation index, however, the correlation with high proliferation index is observed only in photoexposed region in SCC. High proliferative index was significantly lower in AK than in SCC and KA, but in a high percentage (83%) of AK patients there is strong correlation between a moderate proliferation index and tumor localization in photoexposed region. UV radiation, not only damages the DNA of keratinocytes, but also reduces the immune response of the skin and reduces the body's ability to carry out repair adverse change (37, 38).
P53 mutants indicates that the damage is caused by UV light (24, 39) , and the cells which are succumbed to DNA damaging continue to grow and to divide. Typically, the exhibit keratinization disorder is clinically manifested as an area of rough skin. While the changes are localized above the basal membrane, lesions represent a squamous
CONCLUSION
Proliferation index and the index of the expression of p53 are useful for the differentiation of precursor lesions from keratinocyte skin carcinoma. Overexpression of p53 is associated with the process of aging and significantly correlated with exposure to UV radiation, especially in the SCC and AK.
Finally, high expression of Ki67 is a good indicator of proliferative activity, and high expression of p53 in AK and SCC supports additional pathogenetic significance of this oncoprotein in carcinogenesis of the skin.
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cell carcinoma "in situ". At some point, malignant cells can penetrate into the dermis, to give the invasive squamous cell carcinoma. Period of evolution is about 10-20 years and probably about 8-20% of actinic keratoses develop into squamous cell carcinoma. It is believed that patients with actinic keratoses are about 200 times more likely to develop squamous cell carcinoma (1) . Changes ascending and infiltration, multiple ulcerations and inflammation of the surrounding are clinical signs suggestive of malignancy (40) .
Sporadically there are suggestions that solar keratosis should be considered as squamous cell carcinoma "de novo", and not as a pre-cancerous lesion that evolves into squamous cell carcinoma. (41, 8) , yet in the literature there is consistent view that the disease is classified into the precursor of squamous cell carcinoma (1, 2, 37). Numerous intraepidermal proliferative disorders can be precursors of squamous cell carcinoma but actinic keratoses are characterized by a dysplastic epithelium usually on body parts exposed to the sun (19, 20) .
High proliferative index in KA, observed in our study, which is no different from the index of proliferation in the SCC, was also reported by other authors, but unlike many other authors (1, 35, 37, 39) we haven't observed association of KA with exposure to ultraviolet radiation. In addition, in this study the expression of p53 in KA did not positively correlated with tumor localization on photoexposed region, such as in the case with the SCC and AK. This points to a complex phenotype and heterogeneous etiology of KA. Speaking in favor of that, also goes a recent findings in the statement that KA is a separate entity caused by alteration of the TGFβ signaling pathway (42) .
In line with other reports (22, 32) are our findings that there is significant association between the age of patients and the type of tumor keratinocyte, respectively our patients with SCC are significantly older than patients AK and KA. We also observed significant correlation between age of patients and p53 expression. Specifically in subjects younger than 60 years of age, significantly more common was high index of p53 expression in SCC then in other keratinocyte tumors, but with age, expression of p53 increases in the AK which could explain the prolonged exposure to UV radiation. Similar observations have been published by Turkish authors who have furthermore pointed out a strong correlation with the p53 expression to the tumor size in AK (22) . Our correlation analysis identified a significant association of the proliferation index and the expression of p53 only in the SCC, which has also been observed by other authors (43, 44) . In all age groups, in this study, a high proliferative index was significantly more frequent in SCC and KA than in AK.
Between the type of tumor and gender we did not find a significant association but we have noted that the SCC is slightly more frequent in male patients, and accordingly, there are reports according to which SCC occurs in males 2: 1 to 3. 3: 1 ratio in relation to females (45, 46) 
